(2019) 63:e1801419
Putting myself in Pfizers shoes, the real kicker, beyond the potential for a better product profile, is how the potency and dosing of Metseras molecules lower API requirements and impact COGs
Readers are strongly encouraged to consult with a qualified healthcare regulatory attorney and to monitor updates from the U.S
My current go to is a bone broth smoothie bowl with a few berries on the side
Indeed, only 2 months later (September 2023), Intuitive was already fielding worst case scenarios conference questions: People are sitting there worried, well, bariatric is going to slow, I don't know how much because of GLP-1s
While some studies have shown the effectiveness of these drugs in kidney transplantation, there remains a limited number of clinical trials specifically focused on liver transplantation